2017
DOI: 10.1016/j.placenta.2017.04.016
|View full text |Cite
|
Sign up to set email alerts
|

Relative amount of telomeric sequences in terminal villi does not differ between normal term placentas and placentas from patients with well-controlled type 1 diabetes mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
4
1
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 15 publications
0
8
0
Order By: Relevance
“…In the same groups of patients, the immunohistochemically identified telomerase expression, the expression of mRNA for hTERT, and the expression of TERC gene copy number were lower in diabetic placentas [41]. On the other hand, no difference of mean telomere length was found in peripheral villi of normal placentas and placentas in well-controlled maternal diabetes examined by laser capture microdissection and qPCR [35], although the study on the same placental material discovered lower proliferative potential of cytotrophoblast and vascular endothelium of terminal villi in maternal diabetes [25]. Single telomere length analysis (STELA) was used for measurement of telomere length in normal placentas and placentas from gestational diabetes treated either by lifestyle intervention or by metformin or insulin therapy.…”
Section: Maternal Diabetes Mellitusmentioning
confidence: 79%
See 3 more Smart Citations
“…In the same groups of patients, the immunohistochemically identified telomerase expression, the expression of mRNA for hTERT, and the expression of TERC gene copy number were lower in diabetic placentas [41]. On the other hand, no difference of mean telomere length was found in peripheral villi of normal placentas and placentas in well-controlled maternal diabetes examined by laser capture microdissection and qPCR [35], although the study on the same placental material discovered lower proliferative potential of cytotrophoblast and vascular endothelium of terminal villi in maternal diabetes [25]. Single telomere length analysis (STELA) was used for measurement of telomere length in normal placentas and placentas from gestational diabetes treated either by lifestyle intervention or by metformin or insulin therapy.…”
Section: Maternal Diabetes Mellitusmentioning
confidence: 79%
“…Telomere length analysis based on isolated DNA TRF [29][30][31] STELA [32][33][34] Q-PCR, T/S ratio [29,[35][36][37][38] Telomere length analysis based on examination of interphase nuclei…”
Section: Methods Referencesmentioning
confidence: 99%
See 2 more Smart Citations
“…40,41 Nevertheless, Zinková et al found no differences in TL between controls and well-controlled type 1 diabetes mellitus placental samples. 42 Although these studies have some methodological differences, [40][41][42] it suggests that a good disease management (leading to well-controlled diabetes) may prevent the detrimental effect of hyperglycemia over placenta aging.…”
Section: The Disturbance Of Telomere Dynamics In Fetal Membranes Contributes To Pregnancy Complicationsmentioning
confidence: 99%